Benefits
Total and free testosterone increase across 4 RCTs
TestFACTOR® is backed by four published, gold-standard randomized, double-blind, placebo-controlled clinical studies demonstrating consistent testosterone elevation. The most recent study (2024) in 60 recreationally active men aged 40–65 showed a 19% increase in total testosterone and 30–40% increase in free testosterone at 325 mg/day — the most clinically significant free testosterone increase documented for a botanical ingredient.
Sexual function improvement — desire, frequency, and pleasure
The fourth clinical study specifically targeting sexual health confirmed TestFACTOR® significantly enhanced overall sexual function including sexual desire, frequency of sexual activity, sexual pleasure, and other key sexual function metrics vs. placebo. These real-world sexual wellness outcomes are rarely documented in clinical trials for testosterone support ingredients, making TestFACTOR®'s evidence base exceptionally strong for this application.
Reduced fatigue and improved energy
The sexual health study also documented significant reductions in both mental and physical fatigue with TestFACTOR® supplementation — consistent with testosterone's established role in energy regulation, motivation, and physical capacity. This fatigue-reducing benefit extends the ingredient's value beyond sexual wellness into broader men's vitality and active aging applications.
Grip strength improvement
Improved grip strength was confirmed in clinical assessment — providing an objective physical performance measure alongside subjective sexual wellness outcomes. Grip strength is a validated biomarker of overall physical vitality and metabolic health, and its improvement with TestFACTOR® reflects the broad anabolic and vitality-enhancing effects of optimized testosterone levels.
Mechanism of action
LH stimulation and Leydig cell testosterone biosynthesis enhancement
Sphaeranthus indicus bioactives (sesquiterpene lactones including 7-hydroxyfrullanolide) stimulate hypothalamic-pituitary LH (luteinizing hormone) secretion — the primary hormonal signal driving testicular Leydig cell testosterone synthesis. Mangifera indica bark polyphenols (mangiferin, norathyriol) enhance cholesterol side-chain cleavage enzyme (CYP11A1) activity in Leydig cells, improving the efficiency of testosterone biosynthesis from cholesterol. This dual upstream stimulation (LH signaling) and downstream enhancement (biosynthetic enzyme activity) explains TestFACTOR®'s consistent testosterone elevation across multiple clinical trials.
Clinical trials
Randomized, double-blind, placebo-controlled 8-week trial of TestFACTOR® (325 mg/day) in 60 healthy recreationally active men aged 40–65. Primary outcome: sexual function composite score. Secondary: total and free testosterone, fatigue, grip strength.
60 men aged 40–65 years, BMI 22–29.9 kg/m², baseline testosterone ≥300 ng/dL. 8-week double-blind, randomized, placebo-controlled trial; same Sphaeranthus indicus + Mangifera indica formulation as RipFACTOR® positioned for sexual wellness.
TestFACTOR® significantly improved overall sexual function composite score, including desire, frequency, and pleasure vs placebo. ~19% total testosterone increase, 30–40% free testosterone increase. Significant reduction in mental and physical fatigue (POMS). Improved grip strength.
Three prior randomized, double-blind, placebo-controlled trials across dose levels and populations documenting consistent testosterone, strength, and endurance benefits.
Resistance-trained men. 12-week randomized double-blind placebo-controlled trial of the same proprietary 2:1 Sphaeranthus indicus flower + Mangifera indica bark extract powering RipFACTOR® and TestFACTOR®.
Significant increases in total and free testosterone, testosterone:cortisol ratio, strength endpoints, and lean body mass vs placebo. Forms the foundational RCT supporting both RipFACTOR® (sports nutrition) and TestFACTOR® (sexual wellness/testosterone) marketing.